Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Calcivis

Explore full profile

Biotechnology-driven imaging system for early detection and prevention of tooth demineralization

Edinburgh, United KingdomFounded 2011Biotech & Life Sciences
Valuation $25–50M Last recorded · 2024
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Calcivis and the history behind them.

About Calcivis

CALCIVIS is a pioneering company in the field of preventive dentistry, offering an innovative solution to help dental clinicians detect and manage active tooth demineralization. The company's flagship product, the Calcivis Imaging System, is a state-of-the-art device that resembles a standard intraoral camera. This system allows dentists and their patients to see calcium ions being released from a demineralizing tooth surface in real-time. This visualization is made possible through the use of a recombinant bioluminescent photoprotein, which reacts with free calcium ions to produce light.

The primary market for CALCIVIS includes dental clinics and practitioners who are focused on preventive care. By enabling early detection of tooth decay, the Calcivis Imaging System helps clinicians intervene before cavities develop, potentially reversing the decay process and avoiding the need for more invasive treatments like drilling and filling.

CALCIVIS operates within the dental healthcare market, specifically targeting issues related to caries diagnosis and preventive management. The company's business model revolves around selling the Calcivis Imaging System to dental practices, along with providing ongoing support and maintenance services. Revenue is generated through the sale of the imaging systems, as well as through service contracts and potential future updates or enhancements to the technology.

In summary, CALCIVIS offers a groundbreaking technology that empowers dental professionals to adopt a minimal intervention approach to dentistry. By providing visual evidence of active tooth decay, the system not only aids in accurate diagnosis but also encourages patient compliance with preventive measures.

Source: Dealroom company data

At a glance

Founded
2011
Headquarters
Edinburgh, United Kingdom
Sector
Biotech & Life Sciences

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Innovation Council

Series A7 investors entered at this stage

  • Archangels
  • Scottish Enterprise Growth Investments
  • Julz
  • Lynx Financial Group
  • Scottish National Investment Bank
  • Maven Capital Partners
  • British Business Bank
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom69.2%
🇺🇸 United States30.8%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Calcivis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Calcivis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.